Does IDURSULFASE Cause Psychomotor hyperactivity? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Psychomotor hyperactivity have been filed in association with IDURSULFASE (ELAPRASE). This represents 0.7% of all adverse event reports for IDURSULFASE.
23
Reports of Psychomotor hyperactivity with IDURSULFASE
0.7%
of all IDURSULFASE reports
0
Deaths
17
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From IDURSULFASE?
Of the 23 reports, 17 (73.9%) required hospitalization, and 2 (8.7%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDURSULFASE. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does IDURSULFASE Cause?
Pyrexia (524)
Product dose omission issue (450)
Inappropriate schedule of product administration (371)
Cough (263)
Infusion related reaction (241)
Pneumonia (232)
Death (222)
Dyspnoea (202)
Influenza (200)
Covid-19 (197)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which IDURSULFASE Alternatives Have Lower Psychomotor hyperactivity Risk?
IDURSULFASE vs IFOSFAMIDE
IDURSULFASE vs IGURATIMOD
IDURSULFASE vs ILOPERIDONE
IDURSULFASE vs ILOPROST
IDURSULFASE vs IMATINIB